Maturation of sensory systems in mammals is regulated by appropriate sensory stimulation.
Introduction
Melanopsin is a G-coupled receptor that, like other opsins [1] [2] [3] [4] , initiates a signaling cascade when it captures a photon of light. Melanopsin was discovered in the melanophores of the frog Xenopus laevis 5 but is now known to be present in most vertebrates 6 . In adult mice, melanopsin mediates circadian entrainment [7] [8] [9] [10] and the pupillary light reflex 9, 11 . More recently, melanopsin was shown to be essential for negative phototaxis in neonates 12 and for normal vascular development of the eye 13 .
In mammals, melanopsin is expressed in so-called intrinsically photosensitive retinal ganglion cells (ipRGCs). The axons of ipRGCs project to several regions of the brain, such as the suprachiasmatic nucleus (SCN) [14] [15] [16] [17] [18] and the olivary pretectal nucleus 11, 17, [19] [20] [21] [22] , that are consistent with the light-sensing physiological functions of melanopsin. It has been shown that melanopsin expressing cells are photo-sensitive as early as the day of birth (P1) in the mouse 23 . This is 9 days prior to the emergence of visual signaling from conventional photoreceptors, consistent with the acute action of melanopsin in the negative phototaxis reflex of mice at P5 12 . Several studies have demonstrated that ipRGCs express Gnaq/11 subfamily members [24] [25] [26] and that melanopsin phototransduction is predominantly mediated by Gnaq/11 coupling 24, 27, 28 . Other reports suggest that melanopsin functions independent of Gnaq/11 both in vivo 26 and in vitro [29] [30] [31] . The in vivo studies were performed in neonatal pups or adult animals, and the nature of melanopsin phototransduction in fetal retina remains to be explored.
Melanopsin is required for normal vascular development of the mouse eye 13 . Mice that are dark reared from E15 or that are Opn4 loss-of-function show promiscuous retinal angiogenesis and hyaloid vessel persistence 13 . A model explaining melanopsin-dependent vascular development suggests that the first step is the suppression of retinal neuron numbers 13 . It is proposed that in Opn4 null and dark reared mice, abnormally high numbers of retinal neurons induce a hypoxia response that results in high expression of vascular endothelial growth factor A, (VEGFA) 13 , a key regulator of developmental angiogenesis. In turn, high levels of VEGFA are proposed to cause promiscuous angiogenesis in the retina as well as to suppress regression of the hyaloid vessels 13 . One unusual outcome of this analysis was the proposal, based on staged dark rearing experiments, that the light response window for melanopsin-dependent vascular development occurs during gestation between E16 and E18 13 . This further implied that melanopsin in the fetal retina would be stimulated by light that traveled through the body wall of the dam 13 . Measured levels of light within the visceral cavity of adult female mice were consistent with this possibility given the threshold photo-sensitivity of ipRGCs 23, 32, 33 .
In the current study we have used experimental strategies to address the role of melanopsin signaling during fetal mouse stages in regulating vascular development in the eye.
We show that gain-and loss-of-function modulation of GNAQ (Gaq) in Opn4-expressing cells results in changes in vascular development. Importantly, Gnaq loss-of-function phenocopies lossof-function for Opn4 while GNAQ gain-of-function restricted to fetal Opn4-expressing cells reverses the vascular consequences of dark rearing and Opn4 loss-of-function. These data make a strong case that melanopsin function via GNAQ signaling during fetal stages is necessary and sufficient for vascular maturation in the eye. Given the OPN4 gene is expressed at gestational week 9 in human eyes 34 , these findings also raise the very interesting possibility that this same pathway may be conserved in the human fetus.
Results

Gnaq loss-of-function in Opn4-expressing cells phenocopies Opn4 mutation
In order to employ manipulations of G-protein signaling to investigate fetal ipRGC vascular development responses, we first needed to establish which G-protein was involved. If ipRGCs employ GNAQ for melanopsin phototransduction, then a deletion of Gnaq in Opn4-expressing cells in mice should reproduce the vascular development phenotype of the Opn4 null 13 . To test this, we combined the Opn4 cre allele with Gnaq fl (officially Gnaq tm2Soff ) but also included the germline loss-of-function Gna11 allele because GNAQ and GNA11 frequently function together. To assess the consequences of deletion of GNAQ and GNA11 in Opn4-expressing cells, we generated Opn4 cre ; Ai14, Gna11 -/-; Gnaq fl/fl mice and assessed deletion using immunofluorescence detection of GNAQ and GNA11. ipRGCs in the retina were identified by the expression of tdTomato from the Ai14 cre reporter ( Fig. 1A-E ). Use of a single antibody that detects both GNAQ and GNA11 on cryosections from retina revealed that control ipRGCs showed membrane immunoreactivity ( Fig. 1A-E ), but almost all those from mice with combined Gna11
and Gnaq mutations did not ( Fig. 1F -H). A few ipRGCs retained GNAQ/11 labeling ( Fig. 1G , H, red arrow) and probably represent cells that did not recombine both Gnaq fl alleles in response to Opn4 cre . With this evidence for GNAQ/11 loss in ipRGCs, we analyzed the eyes of mutant mice for vascular anomalies.
The hyaloid vessels are fetal blood vessels that reside transiently between lens and retina.
These vessels undergo a maturational regression, presumably as an adaptation to clear the visual axis for high-acuity vision. In the mouse this occurs between postnatal (P) days 1 and 10 35 . Counts of vessel numbers at P8 provides a simple and reliable read-out for regression activity 13, 36 . In P8 Gnaq fl/+ ; Gna11 +/control mice, we observed hyaloid vessel numbers consistent with a normal rate of regression ( Fig. 2A-C) 13, 36 . By contrast, Opn4 cre ; Gnaq fl/+ and Opn4 cre ; Gnaq fl/fl both showed hyaloid persistence. Deleting both alleles of Gnaq produced the highest level of persistence suggesting a gene dose-dependence ( Fig. 2A-C ). The addition of Gna11 germ-line homozygosity to Gnaq conditional deletion in ipRGCs did not further elevate hyaloid vessel number at P8 (Fig.   2C ). These data suggest GNAQ is required in Opn4-expressing cells for activity of the pathway that controls hyaloid regression. The data also suggest that GNA11 is unlikely to be a significant contributor.
As previously shown Opn4 deletion results in persistent hyaloid vessels at P8 13 . For comparison purposes we also show here that Opn4 homozygote null mice show a significant elevation in the number of hyaloid vessels (Fig. 2D ). The absolute numbers of hyaloid vessels in control animals shown in Fig. 2C and 2D is distinct and this very likely reflects differences in strain background. Namely, the data in Fig. 2C are the result of a mixed background cross and that in , we find that GNAQ loss-of-function produces a phenotype that is at least as severe as that for OPN4. This argues that for this vascular development pathway GNAQ activity can fully account for the signaling activity of OPN4.
During the postnatal period in mice, the retina becomes vascularized through a process of angiogenesis in part driven by VEGFA 37 . In the Opn4 null mouse, retinal angiogenesis is promiscuous and the vascular networks show elevated density and ectopic sprouts 13 . For this reason we also assessed development of the retinal vasculature in the Gna11 -, Gnaq fl , Opn4 cre allelic series. Counts of branch-points revealed a gene dosage-dependent elevation in vascular density ( Fig. 2E -G) but, as with the hyaloid vessel phenotype, no apparent contribution from GNA11. When we compared the phenotype severity for GNAQ and OPN4 loss-of-function (as proportion of control, white number Figs. 2G, H), as with the hyaloid vessel phenotype, we found that GNAQ can fully account for the activity of OPN4. Combined, the hyaloid vessel and retinal angiogenesis phenotypes of mice with GNAQ loss-of-function in Opn4-expressing cells suggest that OPN4 signaling for this vascular development pathway is coupled through GNAQ.
Activation of GNAQ at fetal stages reverses the vascular consequences of Opn4 loss-offunction.
To further assess the relationship between light responses, OPN4, GNAQ and vascular development, we determined whether we could reverse the vascular consequences of darkrearing or Opn4 mutation by activating GNAQ signaling only in Opn4-expressing cells. We designed these experiments so that we could activate GNAQ only during late gestation and in fetal mice, not in the pregnant dam. This addressed the question of whether OPN4-dependent signaling responses occurred in fetal mice.
For these experiments, we employed a ROSA26-based allele expressing hM3Dq 38 , a DREADD (Designer Receptors Exclusively Activated by Designer Drugs) based on a G-coupled receptor that activates GNAQ in response to the small molecule ligand CNO 39 . By activating R26-hM3Dq with Opn4 cre (Fig. 3A) , we could obtain expression in Opn4-expressing cells and by injecting CNO into the dam in late gestation ( Fig. 3B ), we could restrict GNAQ activation to fetal stages. We also performed crosses that excluded the possibility of GNAQ activation in the dam.
We used this experimental strategy to generate a series of control and experimental mice that were assessed for both hyaloid vessel regression and retinal vascular density.
For experiments to determine whether GNAQ activation could reverse the vascular consequences of Opn4 loss-of-function, we crossed an Opn4 cre/cre ; R26-hM3Dq male with an Opn4 +/female. This provided appropriate control and experimental genotypes in fetal mice but excluded the possibility that the dam could respond to CNO. We then injected CNO daily from E16 to day of birth (P1) and harvested retina and hyaloid at P8 for quantification of vascular structures. As expected, Opn4 cre/pups showed hyaloid persistence at P8 (Fig. 3C , and the dark gray bar in G). By contrast, Opn4 cre/-; R26-hM3Dq pups injected with CNO showed a normal number of hyaloid vessels (Fig. 3D , and the dark blue bar in G). Similarly, Opn4 cre/animals showed an abnormally elevated retinal vascular density at P8 (Fig. 3F, H) and this was reversed when Opn4 cre/was combined with R26-hM3Dq and gestational CNO (Fig. 3F, H) . These data show that for the vascular development pathways in the eye, GNAQ activity can substitute for OPN4 within ipRGCs. The experiment also makes a strong case that this vascular development pathway is dependent on the activity of melanopsin at fetal stages.
Activation of GNAQ in ipRGCs at fetal stages reverses the vascular consequences of dark rearing.
As a second step in this analysis, we determined whether fetal stage GNAQ activation could reverse the vascular consequences of dark-rearing (DD, Fig. 3B ). For this analysis, we crossed a male Opn4 cre/cre homozygote with a female R26-hM3Dq heterozygote. This meant that half the fetal mice had expression activation of hM3Dq in melanopsin-expressing neurons, but importantly, the dam did not carry Opn4 cre and therefore could not activate expression of R26-hM3Dq. Thus, any response to the CNO ligand could only be attributed to fetal Opn4-expressing cells. When we performed the analysis, we found that CNO injected into pregnant female mice from E15 through E19 reversed the vascular consequences of dark rearing (Fig. 4A-H) . As expected, DD conditions resulted in significantly elevated hyaloid vessel numbers at P8 (Fig. 4A , C, D). In the absence of late gestational injections of CNO the elevated number of hyaloid vessels was not significantly changed with or without hM3Dq (Fig. 4C, D) . However, when CNO was injected from E15 to E19 into DD, Opn4 cre ; R26-hM3Dq mice, the normally elevated number of hyaloid vessels remained at the level observed in the LD control (compare Fig. 4E , blue bar with 4C, both bars). When we quantified retinal vascular branch-points ( Fig. 4F, G, H) , we observed a very similar pattern where Opn4 cre , R26-hM3Dq, and gestational CNO were all required to reverse the retinal vascular overgrowth of DD to control levels (Fig. 4H) . These data indicate that activation of GNAQ signaling in Opn4-expressing cells can substitute for light in late gestation and give normal regulation of vascular development.
Discussion
Here we have combined experimental strategies to address the question of whether melanopsin activation during fetal stages can regulate vascular development in the mouse eye. Within the retina, OPN4 expression is restricted to a subset of retinal ganglion cells (RGCs) that are, in adult mice, intrinsically photosensitive 9, 14, 40 . Opn4 is expressed as early as E10.5 34 and OPN4 protein is detected in the retina around E15 41 in mouse embryos. Like other opsins, melanopsin (aka Opsin 4, OPN4) is a G-coupled receptor 29, 42 and functions predominantly via Gnaq/11 coupling 24, 27, 28 . Few studies have suggested alternate G-protein coupling for melanopsin in both in vivo 26 and in expression systems [29] [30] [31] . Current data on melanopsin G-protein coupling is from adult or neonatal mice. We focused our efforts on late gestational ages and our data indicates that melanopsin in the fetal retina uses conventional Gnaq/11-coupling for ocular vascular development.
In the first step of this analysis, we determined whether the loss of GNAQ function in Opn4expressing cells produced the same phenotype as a melanopsin (OPN4) loss-of-function. We show mice with the Opn4 cre ; Gnaq fl/fl genotype had the retinal vascular overgrowth and hyaloid vessel persistence characteristic of the Opn4 null and of dark rearing from late gestation 13 .
Furthermore, the addition of germ-line Gna11 homozygosity to Gnaq conditional deletion from Opn4-expressing cells did not exacerbate vascular phenotypes. These data argue that GNAQ, and not GNA11, mediates melanopsin-dependent vascular development. As a final step in this series of experiments we determined whether GNAQ gain of function was sufficient to reverse the vascular phenotypes that result from dark rearing or from Opn4 mutation. We tested whether GNAQ activation in Opn4-expressing cells only during the fetal stages of mouse development was sufficient to reverse the vascular changes that normally result from dark rearing or Opn4 lossof-function. Our findings showed that when GNAQ gain-of-function was restricted to Opn4expressing cells in late mouse gestation, this was sufficient to overcome the absence of light or the absence of OPN4 for the vascular development pathway.
These data thus make a strong case that if the vascular development of a mouse eye is to be normal, GNAQ must be activated in Opn4-expressing cells from E16 to E19 of gestation.
The ability to revert the Opn4 loss-of-function phenotype with conditional activation of GNAQ also suggests that the activity of OPN4 and GNAQ in Opn4-expressing cells are directly related. The ability to revert the vascular consequences of dark rearing also indicate that the fetal retina normally responds to environmental light. We show that the fetal light response pathway regulating vascular development requires GNAQ but not GNA11 (Fig. 2) . Involvement of GNA14 in the fetal ipRGC response remains a possibility though this is unlikely given the quantitative correspondence between Opn4 and Gnaq loss-of-function.
Multiple members of the Gnaq/11 subfamily, including Gna14, Gnaq and Gna11, can participate in melanopsin phototransduction in vivo 24, 27, 28 . However, a recent study showed that Opn4 cre ; Gna11 -/-; Gnaq fl/fl mice like those used here, many of the photic responses ascribed to melanopsin remain normal 26 . The present analysis, showing that GNA11 does not contribute to vascular development responses, is consistent with the documented lack of a multielectrode array response in the neonatal retina of Gna11; Gna14 null mice 26 . However, the Gnaq loss-of-function phenotype, coupled to the rescue of the OPN4 loss-of-function phenotype by GNAQ gain-offunction, makes a compelling case that GNAQ is an important signaling mediator of OPN4 activity in fetal stages and is consistent with the observation of GNAQ presence in all M1-5 ipRGCs in adult mice 24 . One possible explanation for these apparently discrepant findings is that different functions of melanopsin are mediated by distinct types of signaling response and are likely to be age-specific. One scenario is that perhaps the vascular development pathway assessed here relies on the activity of GNAQ while the pupillary reflex and circadian photoentrainment rely on other G-proteins that are expressed at a later stage of ipRGC development.
The data presented here make a strong case that the eye of a fetal mouse uses light as normal developmental cue. Though we currently do not understand the biological rationale with precision, it is quite likely that the fetal eye light response prepares the eye for visual function.
Certainly, vascular development of the eye must be closely regulated for normal vision but it is also likely that other responses to fetal OPN4 stimulation will be identified. OPN4 is highly conserved within the vertebrates both in primary sequence and function. This raises the fascinating possibility that the human fetal eye is also light responsive in a way that regulates vascular development. This idea has received support from a recent clinical study that associates first trimester fetal light exposure with severe forms of retinopathy of prematurity, an ocular blood vessel overgrowth of the premature infant 43 .
Materials and Methods
Animals
All animal experimentation was carried out using protocols approved by the Institutional Animal Care and Use Committee at Cincinnati Children's Hospital Medical Center. Mouse lines used in this study have been previously described: Opn4 cre (ref 44 ) Opn4 -(ref 10 ), Ai14 (JAX #007914) , Gnaq fl (ref 45 ), Gna11 (ref 45 ) and R26-LSL-Gq-DREADD (ref 38 ). Genotyping information is described in the cited publications. Mice were housed in a 12:12 hour light-dark (LD) cycle. For dark-rearing experiments, pregnant dam was moved to constant darkness (DD) after lights OFF at E15. Clozapine-N-oxide (CNO, Sigma #CO832-5MG) stock solution was prepared at 10 mg/ml in 100% DMSO and injected into the dam at 1 mg/kg body weight to activate Gq-DREADD (hM3Dq). Dam was injected daily at lights ON in LD cycle or at subjective lights ON for animals in DD from embryonic day E16 to day of birth. For DD animals, injections were performed under dim red light. Littermate controls were used for all experiments to accommodate for differences in mouse strains.
Hyaloid and retinal labeling
Hyaloid vessel and retinal flat-mount preparations have been previously described (Rao 2013) .
Hyaloid preparations and retinae were labeled with Hoechst 33258 and isolectin (1:500, Thermo Fisher Scientific #I21411), respectively. Hyaloid vessel quantification has been described previously (Rao 2013 ). Retinal vessel density was quantified by counting vessel junctions using ImageJ for at least ten 320µm 2 fields per retina. We used paired T-test to assess statistical significance. In the G-protein immunohistochemical study, retinae for cryosections were fixed at room temperature for 2 hours in 4% PFA and then cryopreserved in 30% sucrose and sectioned at 10 µm followed by antigen retrieval with ice cold sodium citrate buffer for 10 minutes. Sections and flat-mounts were incubated in anti-GNAQ/GNA11 (1:100, Santa Cruz sc-392) at 4 o C for 1-3 days followed by secondary antibody (1:500, Thermo Fisher Scientific #A-21206) overnight at 
